Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides

   
   

The object of the present invention is to find new effects of natriuretic peptides in an ophthalmological field. The present invention provides eyedrops for promoting lacrimal secretion or for treating keratoconjunctival disorders containing the natriuretic peptide as active ingredient. The natriuretic peptides are atrial natriuretic peptides (ANP), brain natriuretic peptides (BNP) and C-type natriuretic peptides (CNP). Typical examples of the keratoconjunctival disorder are dry eye, corneal erosion and corneal ulcer.

L'oggetto di presente invenzione รจ trovare i nuovi effetti dei peptidi natriuretic in un campo ophthalmological. La presente invenzione fornisce i eyedrops per la promozione della secrezione lacrimal o per i disordini keratoconjunctival trattanti che contengono il peptide natriuretic come ingrediente attivo. I peptidi natriuretic sono peptidi natriuretic atriali (ANP), peptidi natriuretic del cervello (BNP) e C-tipo i peptidi natriuretic (CNP). Gli esempi tipici del disordine keratoconjunctival sono occhio asciutto, erosione corneale ed ulcera corneale.

 
Web www.patentalert.com

< Injectable formulations containing ramoplanin

< Interferon tau mutants and methods for making them

> Method for treating soil for the control of soil borne plant pathogens

> Liquid dispersion polymer compositions, their preparation and their use

~ 00151